Jobs
-
DDL 22 committee member Mark Hammond has organized a new group on LinkedIn called “DDL Conference” in order to “provide updates to the programme and this years conference as they become available and also give… Read more . . .
-
A Phase 1 clinical trial of an inhaled dry powder formulation of atropine for the treatment of nerve agent poisoning has been completed successfully, according to MicroDose Therapeutx. MicroDose subsidiary MicroDose Defense Products is developing… Read more . . .
-
Copley Scientific will introduce its new breath simulator at the upcoming ISAM 2011 congress in Rotterdam, The Netherlands. New pharmacopoeial testing specifications for nebulizers take effect in August 2011, and the new breath simulator allows… Read more . . .
-
The US FDA has accepted the filing of the new drug application for its ciclesonide nasal aerosol, according to Nycomed and Sunovion. The product is an HFA formulation of ciclesonide delivered by a metered dose… Read more . . .
-
Canadian biotech company Asmacure has announced that Martin Driscoll will replace Luc Vachon as Chief Executive Officer. Vachon is leaving the company “to pursue other business ventures.” Asmacure is developing an inhaled nictonic receptor agonist,… Read more . . .
-
GSK and Theravance have announced results for two Phase 3 studies of its ICS/LABA combo DPI Relovair for the treatment of COPD. The product combines fluticasone furoate and vilanterol. The companies said that the studies… Read more . . .
-
Jan De Backer, CEO of Antwerp-based FluidDA, calculates that the combination of biomedical imaging and computational fluid dynamics offered by his company has the potential to reduce development costs for OINDPs by hundreds of millions… Read more . . .
-
Aptar Pharma is touting the use of its “Classic” modular spray pump in the recently launched Sprix ketorolac tromethamine nasal spray from Regency Therapeutics. Regency is a new division of Luitpold Pharmaceuticals, which acquired Sprix… Read more . . .
-
Generex Biotechnology has reached an agreement with Amarantus BioSciences regarding Generex’s RapidMist buccal aerosol delivery system. The RapidMist device is a modified metered dose inhaler that delivers the aerosol to the lining of the mouth… Read more . . .
-
Rigel Pharmaceuticals has said that it is raising approximately $130.4 million as the result of a stock offering involving 16.3 million new shares. The company says that it expects the offer to close on or… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland